AlphaStocks

EGBN vs TMP

EAGLE BANCORP INC vs TOMPKINS FINANCIAL CORP — Side-by-Side Stock Comparison

EGBN

EAGLE BANCORP INC

4.4

Weak

$25.37

TMP

TOMPKINS FINANCIAL CORP

8.7

Strong Buy

$79.71

EGBN vs TMP: Which is the Better Investment?

EAGLE BANCORP INC (EGBN) scores 4.4/10 while TOMPKINS FINANCIAL CORP (TMP) scores 8.7/10 on AlphaStocks' composite model. TOMPKINS FINANCIAL CORP has the higher composite rating of Strong Buy.

This comparison is algorithmically generated and is not financial advice.

MetricEGBNTMP
Scores & Fundamentals
Composite Score4.4/108.7/10
RatingWeakStrong Buy
Price$25.37$79.71
P/E Ratio7.1
ROE-12.2%18.7%
Market Cap$769.9M$1B
Fair Value$100.45
Dividend Yield2.0%3.3%
Sector Rank#87 of 97#2 of 97
Model Verdicts
PiotroskiCautionAttractive
BuffettCautionStrong
GrahamNeutralStrong
LynchLimited DataLimited Data
GreenblattLimited DataLimited Data
View full EGBNanalysis →View full TMPanalysis →
Compare any two stocks →

EGBN vs TMP: Which Stock Scores Higher?

EAGLE BANCORP INC (EGBN) and TOMPKINS FINANCIAL CORP (TMP) are among the most compared stocks in the Financials sector. TMP currently leads with a composite score of 8.7/10 (Strong Buy) compared to EGBN's 4.4/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer